Niagen Bioscience, Inc. (NAGE) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-07-08

Niagen Bioscience, Inc. (NAGE) has filed 11 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-08. 2 Form 8-K material event filings were reported by NAGE in the last 90 days. InsiderAlpha tracks every NAGE SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Niagen Bioscience, Inc. (NAGE)

SEC CIK	0001386570

90-Day SEC Filing Activity

Form 4 filings (90d)	11
Form 8-K filings (90d)	2
Latest Form 4 filing	2026-07-08

Recent NAGE Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-06-30	Lopez Carlos Luis	SVP, General Counsel	A — Grant or award	2.3K	$2.71	$6K	SEC
2026-06-30	Fried Robert N	Chief Executive Officer	A — Grant or award	1.1K	$2.71	$3K	SEC
2026-06-30	Pamir Ozan	Chief Financial Officer	A — Grant or award	4.3K	$2.71	$12K	SEC
2026-04-24	Fried Robert N	Chief Executive Officer	M — Option exercise	20.0K	$2.61	$52K	SEC
2024-12-13	Jaksch Frank L Jr	Director	M — Option exercise	50.0K	$3.66	$183K	SEC
2024-12-13	Jaksch Frank L Jr	Director	S — Open-market sale	37.2K	$6.19	$230K	SEC
2024-11-22	Pamir Ozan	Chief Financial Officer	P — Open-market purchase	2.9K	$7.36	$21K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Niagen Bioscience, Inc. (NAGE). Updated in real time as new filings are submitted to the SEC.

Most-Active NAGE Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Fried Robert N	3	$55K
Rubin Steven D	1	—
Pamir Ozan	1	$12K
Jaksch Frank L Jr	1	—
Lopez Carlos Luis	1	$6K

Recent NAGE Form 8-K Material Events

2026-06-29 — Item 5.07 [SEC]
2026-05-06 — Item 2.02, 7.01, 9.01 [SEC]
2026-03-19 — Item 8.01, 9.01 · Other · neutral [SEC]
Niagen Bioscience's Board of Directors approved an increase in the company's share repurchase authorization from $10.0 million to $20.0 million on March 19, 2026. The company has repurchased approximately $2.6 million of common stock through March 17, 2026, and the expanded progr
2026-03-04 — Item 2.02, 7.01, 9.01 · Earnings · neutral [SEC]
Niagen Bioscience announced financial results for Q4 2025 and full year 2025 via press release and corporate presentation on March 4, 2026. The filing provides standard results reporting without explicit beat/miss language or forward guidance changes.
2026-02-26 — Item 7.01, 8.01, 9.01 · Acquisition · neutral [SEC]
Niagen Bioscience (ChromaDex) completed the sale of its analytical reference standards and services business to VHG Labs (LGC Group) in an all-cash transaction on February 24, 2026. The divestiture is part of the company's stated strategy to exit non-core activities and focus on

Recent Insider Filings

2026-07-08 — Lopez Carlos Luis (SVP, General Counsel)
2026-07-08 — Pamir Ozan (Chief Financial Officer)
2026-07-08 — Fried Robert N (Chief Executive Officer)
2026-06-26 — YU Wing Tak Wendy (Director)
2026-06-26 — Ng Wang Yu Gary (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in NAGE insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

NAGE Insider Trading — FAQ

What is the latest insider trade for NAGE?: Niagen Bioscience, Inc. (NAGE) had 11 insider filings in the last 90 days, with the most recent on 2026-07-08. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying NAGE stock?: 0 insider purchases of NAGE were filed in the last 90 days.
How many insiders are selling NAGE stock?: 0 insider sales of NAGE were filed in the last 90 days.
Where can I see NAGE SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every NAGE SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live NAGE dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.